Xencor, Inc. XNCR
38.59 USD +2.84 (+7.94%)
At closeNov 9, 2026, 4:44 PM EST
38.59 0.00 0.00%
After hours · Nov 9, 4:44 PM ET
35.97 Day range 39.68
10.38 52-week range 39.68
- YTD
- +152.06%
- 1 year
- +177.63%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 41.75 +8.2% upside
Now 38.59
- Target (low)
- 21.00
- Target (mean)
- 41.75
- Target (high)
- 70.00
Ratings (0m) 14 12 buy · 2 hold · 0 sell
- Strong buy3
- Buy9
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.86523 | -1.30 – -0.33 | -0.09 | -861.4% | 30.63M | +8.5% | 10 |
| Next quarter | -0.9625 | -1.20 – -0.70 | -1.71 | +43.7% | 17.92M | +296.8% | 6 |
| Current year | -2.21 | -2.55 – -1.82 | -1.24 | -78.2% | 200.69M | +59.8% | 8 |
| Next year | -3.76 | -5.00 – -2.80 | -2.21 | -70.0% | 115.97M | -42.2% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 27, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 27, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 21, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 28, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Sep 21, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Sep 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 3, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 1, 2026 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 11, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Mar 24, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Feb 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| Dec 17, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 24, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 6, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 6, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 29, 2025 | Barclays | Upgrade | Underweight | Overweight |
| Oct 27, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 3, 2025 | B of A Securities | Downgrade | Buy | Neutral |
| Sep 2, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 21, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
